Literature DB >> 32615278

TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes.

Fengwen Li1, Yinan Zhang2, Huizhi Li3, Jingyi Lu1, Lan Jiang4, Robert A Vigersky5, Jian Zhou1, Congrong Wang6, Yuqian Bao1, Weiping Jia7.   

Abstract

AIMS: Continuous glucose monitoring (CGM)-derived time-in-range (TIR) of 3.9-10 mmol/L is associated with diabetic retinopathy in type 2 diabetes (T2DM), but its relationship to peripheral nerve function has not been previously investigated. To explore the association between the TIR and nerve conduction study parameters in patients with T2DM, we performed a cross-sectional analysis.
METHODS: A total of 740 patients with T2DM were enrolled in this study. All of the participants were divided into tertiles according to the TIR (TIR low: ≤53%; TIR medium: 54-76%; TIR high: ≥77%). Composite Z-scores of nerve conduction velocity (CV), latency, and amplitude were calculated. The linear correlation between the TIR and composite nerve function Z-score was evaluated and risk assessment was analysed using binary logistic regression.
RESULTS: The composite Z-score of the CV and amplitude increased with higher TIR and the composite Z-score of latency significantly decreased as the TIR tertiles increased (all P trend < 0.05). After adjusting for age, diabetes duration, height, weight and other confounding factors, higher TIR was associated with a higher composite Z-score of CV (β = 0.230, P < 0.001), amplitude (β = 0.099, P = 0.010), and lower composite Z-score of latency (β = -0.172, P < 0.001). The risk of TIR tertiles and low composite Z-score of CV remained significant even after adjustment of HbA1c (TIR medium: OR = 0.48, P = 0.001; TIR high: OR = 0.41, P < 0.001).
CONCLUSIONS: Higher TIR tertiles were independently associated with better peripheral nerve function. CGM-derived TIR may be a promising approach to screen patients for further assessment of possible diabetic peripheral neuropathy.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Composite Z-score; Diabetic peripheral neuropathy; Nerve conduction study; T2DM; TIR

Mesh:

Substances:

Year:  2020        PMID: 32615278     DOI: 10.1016/j.diabres.2020.108289

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  11 in total

1.  HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis.

Authors:  Jordan E Perlman; Theodore A Gooley; Bridget McNulty; Jedidiah Meyers; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2020-12-01       Impact factor: 6.118

2.  Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review.

Authors:  Rishi Raj; Vivek Joshi; Rahul Mishra; Nivedita Jha; Ricardo Correa; Philip A Kern
Journal:  BMJ Open Diabetes Res Care       Date:  2022-01

3.  Plasma 1,5-anhydro-D-glucitol is associated with peripheral nerve function and diabetic peripheral neuropathy in patients with type 2 diabetes and mild-to-moderate hyperglycemia.

Authors:  Feng Xu; Li-Hua Zhao; Xiao-Hua Wang; Chun-Hua Wang; Chao Yu; Xiu-Lin Zhang; Li-Yan Ning; Hai-Yan Huang; Jian-Bin Su; Xue-Qin Wang
Journal:  Diabetol Metab Syndr       Date:  2022-01-29       Impact factor: 3.320

Review 4.  Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World.

Authors:  Judith L Glennie; Lori Berard; Fleur Levrat-Guillen
Journal:  Clinicoecon Outcomes Res       Date:  2022-02-10

Review 5.  The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review.

Authors:  Evanthia Gouveri; Nikolaos Papanas
Journal:  Diabetes Ther       Date:  2022-04-08       Impact factor: 3.595

Review 6.  Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.

Authors:  Michael Yapanis; Steven James; Maria E Craig; David O'Neal; Elif I Ekinci
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

Review 7.  Utilizing the New Glucometrics: A Practical Guide to Ambulatory Glucose Profile Interpretation.

Authors:  John Doupis; Edward S Horton
Journal:  touchREV Endocrinol       Date:  2022-06-13

8.  Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes.

Authors:  Chao Yu; Lei Zhuang; Feng Xu; Li-Hua Zhao; Xiao-Hua Wang; Chun-Hua Wang; Li-Yan Ning; Xiu-Lin Zhang; Dong-Mei Zhang; Xue-Qin Wang; Jian-Bin Su
Journal:  Front Endocrinol (Lausanne)       Date:  2022-10-04       Impact factor: 6.055

9.  Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.

Authors:  Yuting Ruan; Jiana Zhong; Rongping Chen; Zhen Zhang; Dixing Liu; Jia Sun; Hong Chen
Journal:  J Diabetes Res       Date:  2021-05-28       Impact factor: 4.011

10.  Association of platelet count and plateletcrit with nerve conduction function and peripheral neuropathy in patients with type 2 diabetes mellitus.

Authors:  Yuqin Qian; Yaying Zeng; Qingxia Lin; Huanjie Huang; Wanli Zhang; Huan Yu; Binbin Deng
Journal:  J Diabetes Investig       Date:  2021-03-23       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.